Antibody-Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond.

Saved in:
Bibliographic Details
Title: Antibody-Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond.
Authors: Monaca F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Gomez-Randulfe I; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Torres-Jiménez J; Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid, Spain., Agarwal M; Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia., Liu SV; Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia., Paz-Ares L; Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid, Spain., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom. Electronic address: raffaele.califano@nhs.net.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Apr 14, pp. 103726. Date of Electronic Publication: 2026 Apr 14.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2026.103726